ReviewInternational journal of molecular sciences2022

BTN3A: A Promising Immune Checkpoint for Cancer Prognosis and Treatment.

Abdou-Samad Kone et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.